-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA GRANTS FAST TRACK DESIGNATION TO SOTIO’S SOT106 ADC FOR SOFT TISSUE SARCOMA TREATMENT, ACCELERATING CLINICAL DEVELOPMENT

Reuters·08/26/2026 12:00:59

Please log in to view news